Navigation Links
Cervical Cancer Vaccine Under Consideration in Europe

Governments in Europe are considering vaccinating young girls against a virus that causes cervical cancer.//

The Standing Commission for Vaccination at the Robert Koch-Institute in Germany has recommended the universal vaccination of girls aged 12 to 17 years.

The Italian Ministry of Health has announced that vaccination of 12 years old girls in Italy can start as soon as regional vaccination centers are prepared.

Government advisors are considering whether the vaccine should be introduced in the UK.

Human papillomaviruses (HPVs) are a large group or related viruses. They play a part in the development of cervical epithelial cancers. HPV is also associated with skin, oral and anal cancers.

Gardasil, made by Merck and Sanofi Pasteur, offers protection against HPV types 16 and 18, which are responsible for 70% of all cervical cancers. They could also be effective against types 6 and 11, which cause about 90% of cases of genital warts.

UK-based GlaxoSmithKline also has a HPV vaccine, called Cervarix, in development. But it has not yet been licensed in Europe.

Around 80% of sexually active women can expect to have an HPV infection at some point in their lives.

And cervical cancer kills 274,000 women worldwide every year, including 1,120 in the UK.

In an editorial published last year, The Lancet called for mandatory vaccination against HPV for girls in all EU member states once they are 11 or 12.

The issue has been controversial, as some parents fear such vaccines against sexually transmitted viruses could promote underage sex.
'"/>




Page: 1

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Smallpox Vaccine May Help Fight Cervical Cancer
3. Obesity Increases Risk of Cervical Cancer
4. Reducing The Risk Of Cervical Cancer
5. Improving Fertility In Patients With Cervical Cancer
6. Vaccine for Cervical cancer
7. Cervical spinal injury patients may have more damage left undetected
8. Cervical Cancer Vaccine To Be Developed In India
9. Cervical Cancer Can Now Be Better Handled With Gene Silencing Therapy
10. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
11. HPV Vaccines for Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider ... and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ ... Editing System is a complete system for culturing and transfecting human pluripotent ...
(Date:6/24/2016)... ... June 24, 2016 , ... Southern Illinois University ... co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy (MOM). ... Convention Center in Collinsville. , They expect to treat approximately 2,000 ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: